“I didn’t cry when I saw the results because it just looks like how I feel it should,” Max wrote in an email. He cried later, ...

Many patients with ER-positive/HER2-negative advanced breast cancer eventually develop resistance to standard first-line ...

Stress hormone cortisol may play a role in the development of Alzheimer’s disease, particularly in postmenopausal women.

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Vepdegestrant significantly improved outcomes for certain patients with ER-positive, HER2-negative advanced breast cancer ...

Experts have highlighted a surprisingly simple and cost-free strategy to fight India’s growing burden of non-communicable diseases. With salt intake far exceeding safe limits, the focus is now on ...

Low estrogen can sneak up on you with symptoms that are easy to overlook. This piece highlights subtle signs your body might ...

NEW HAVEN, CT and NEW YORK, NY, USA I May 31, 2025 I Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase ...

The Itovebi (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast ...